New Research: Key Drivers of Growth for Five Below, Progenics Pharmaceuticals, Advanced Micro Devices, Agilysys, Altair Engineering, and Semtech — Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, June 21, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Five Below, Inc. (NASDAQ:FIVE), Progenics Pharmaceuticals Inc. (NASDAQ:PGNX), Advanced Micro Devices, Inc. (NASDAQ:AMD), Agilysys, Inc. (NASDAQ:AGYS), Altair Engineering Inc. (NASDAQ:ALTR), and Semtech Corporation (NASDAQ:SMTC), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
FIVE DOWNLOAD: http://Fundamental-Markets.com/register/?so=FIVE
PGNX DOWNLOAD: http://Fundamental-Markets.com/register/?so=PGNX
AMD DOWNLOAD: http://Fundamental-Markets.com/register/?so=AMD
AGYS DOWNLOAD: http://Fundamental-Markets.com/register/?so=AGYS
ALTR DOWNLOAD: http://Fundamental-Markets.com/register/?so=ALTR
SMTC DOWNLOAD: http://Fundamental-Markets.com/register/?so=SMTC
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Five Below, Inc. (NASDAQ:FIVE), Progenics Pharmaceuticals Inc. (NASDAQ:PGNX), Advanced Micro Devices, Inc. (NASDAQ:AMD), Agilysys, Inc. (NASDAQ:AGYS), Altair Engineering Inc. (NASDAQ:ALTR), and Semtech Corporation (NASDAQ:SMTC) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed June 19th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
FIVE BELOW, INC. (FIVE) REPORT OVERVIEW
Five Below's Recent Financial Performance
For the three months ended April 30th, 2018 vs April 30th, 2017, Five Below reported revenue of $296.32MM vs $232.88MM (up 27.24%) and basic earnings per share $0.39 vs $0.15 (up 160.00%). For the twelve months ended January 31st, 2018 vs January 31st, 2017, Five Below reported revenue of $1,278.21MM vs $1,000.41MM (up 27.77%) and basic earnings per share $1.86 vs $1.31 (up 41.98%). Five Below is expected to report earnings on August 29th, 2018. The report will be for the fiscal period ending July 31st, 2018. The reported EPS for the same quarter last year was $0.30. The estimated EPS forecast for the next fiscal year is $3.00 and is expected to report on March 20th, 2019.
To read the full Five Below, Inc. (FIVE) report, download it here: http://Fundamental-Markets.com/register/?so=FIVE
-----------------------------------------
PROGENICS PHARMACEUTICALS INC. (PGNX) REPORT OVERVIEW
Progenics Pharmaceuticals' Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Progenics Pharmaceuticals reported revenue of $3.19MM vs $2.35MM (up 35.88%) and basic earnings per share -$0.19 vs -$0.23. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Progenics Pharmaceuticals reported revenue of $11.70MM vs $69.43MM (down 83.15%) and basic earnings per share -$0.73 vs $0.15. Progenics Pharmaceuticals is expected to report earnings on August 8th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.24. The estimated EPS forecast for the next fiscal year is -$0.11 and is expected to report on March 14th, 2019.
To read the full Progenics Pharmaceuticals Inc. (PGNX) report, download it here: http://Fundamental-Markets.com/register/?so=PGNX
-----------------------------------------
ADVANCED MICRO DEVICES, INC. (AMD) REPORT OVERVIEW
Advanced Micro Devices' Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Advanced Micro Devices reported revenue of $1,647.00MM vs $1,178.00MM (up 39.81%) and basic earnings per share $0.08 vs -$0.04. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Advanced Micro Devices reported revenue of $5,329.00MM vs $4,272.00MM (up 24.74%) and basic earnings per share $0.04 vs -$0.60. Advanced Micro Devices is expected to report earnings on July 24th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.01. The estimated EPS forecast for the next fiscal year is $0.53 and is expected to report on January 29th, 2019.
To read the full Advanced Micro Devices, Inc. (AMD) report, download it here: http://Fundamental-Markets.com/register/?so=AMD
-----------------------------------------
AGILYSYS, INC. (AGYS) REPORT OVERVIEW
Agilysys' Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Agilysys reported revenue of $32.06MM vs $30.60MM (up 4.75%) and basic earnings per share -$0.02 vs -$0.23. For the twelve months ended March 31st, 2018 vs March 31st, 2017, Agilysys reported revenue of $127.36MM vs $127.68MM (down 0.25%) and basic earnings per share -$0.37 vs -$0.52. Agilysys is expected to report earnings on August 2nd, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.13. The estimated EPS forecast for the next fiscal year is -$0.07 and is expected to report on May 23rd, 2019.
To read the full Agilysys, Inc. (AGYS) report, download it here: http://Fundamental-Markets.com/register/?so=AGYS
-----------------------------------------
ALTAIR ENGINEERING INC. (ALTR) REPORT OVERVIEW
Altair Engineering's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Altair Engineering reported revenue of $91.73MM vs $76.88MM (up 19.31%) and basic earnings per share $0.06 vs -$0.04. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Altair Engineering reported revenue of $333.33MM vs $313.24MM (up 6.41%) and basic earnings per share -$1.89 vs $0.21. Altair Engineering is expected to report earnings on August 13th, 2018. The report will be for the fiscal period ending June 30th, 2018. The estimated EPS forecast for the next fiscal year is $0.46 and is expected to report on March 20th, 2019.
To read the full Altair Engineering Inc. (ALTR) report, download it here: http://Fundamental-Markets.com/register/?so=ALTR
-----------------------------------------
SEMTECH CORPORATION (SMTC) REPORT OVERVIEW
Semtech's Recent Financial Performance
For the three months ended April 30th, 2018 vs April 30th, 2017, Semtech reported revenue of $130.43MM vs $143.80MM (down 9.30%) and basic earnings per share $0.19 vs $0.18 (up 5.56%). For the twelve months ended January 31st, 2018 vs January 31st, 2017, Semtech reported revenue of $587.85MM vs $544.27MM (up 8.01%) and basic earnings per share $0.55 vs $0.84 (down 34.52%). Semtech is expected to report earnings on August 29th, 2018. The report will be for the fiscal period ending July 31st, 2018. The reported EPS for the same quarter last year was $0.29. The estimated EPS forecast for the next fiscal year is $1.49 and is expected to report on March 13th, 2019.
To read the full Semtech Corporation (SMTC) report, download it here: http://Fundamental-Markets.com/register/?so=SMTC
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.